Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 02, 2020, 07:00 ET Menarini Ricerche Announces C-PRECISE-01, a New Phase Ib/II Trial of MEN1611 in Colorectal Cancer

Menarini Ricerche, the R&D division of the Menarini Group, announced today that it plans to launch in the second-half of 2020 a new phase Ib/II trial ...


Jun 30, 2020, 09:00 ET Neuro-Sys SAS Launches Innovative In Vivo Services in CNS/PNS Field

Today Neuro-Sys, pharmacological Contract Research Services company specialising in the R&D and in vitro testing of molecules used to treat...


Jun 30, 2020, 02:00 ET Thrombosis Research Institute (TRI) Announce ETHIC Trial to Evaluate the Potential Benefits of Early Administration of LMWH in Patients with COVID-19

TRI will conduct an open-label randomized controlled trial of community-based early thromboprophylaxis named ETHIC (Early Thromboprophylaxis in...


Jun 30, 2020, 01:00 ET AOBiome Reports Successful Clinical Trials (Phase 2a in Adults and Phase 1b in Pediatrics) in Pruritus (Itch) Associated with Atopic Dermatitis: Initiates Phase 2b Clinical Trial in Adults

AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammation, announced initiation of a Phase 2b...


Jun 29, 2020, 09:06 ET Medicure Announces Positive Results for AGGRASTAT® in the FABOLUS-FASTER Trial and Publication in the Journal - Circulation

WINNIPEG, MB, June 29, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced...


Jun 29, 2020, 09:00 ET RevImmune Announces Phase II Trial of the T-Cell Growth Factor CYT107 for COVID-19

RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and cancer, announced today that it has...


Jun 29, 2020, 08:30 ET Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Jun 26, 2020, 03:00 ET Philogen Received Clinical Trial Authorisation With Nidlegy in Nonmelanoma Skin Cancer

Philogen S.p.A., a privately-owned biotechnology company, is pleased to announce that the Swiss national competent authority Swissmedic issued the...


Jun 25, 2020, 08:00 ET HempFusion® Participates and Sponsors Industry Leading Study on CBD and Human Health

DENVER, Colo., June 25, 2020 /CNW/ - HempFusion® ("the Company"), a leading dietary supplements company focused on products that contain Hemp/CBD in...


Jun 25, 2020, 07:00 ET Oncolytics Biotech® Announces Investigator Sponsored Phase 2 Trial Evaluating Pelareorep-anti-PD-1 Combination Treatment in Triple-Negative Breast Cancer

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced a new investigator-sponsored triple-negative breast cancer (TNBC) study to be...


Jun 24, 2020, 11:00 ET deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases

Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system, University of Iceland and the...


Jun 24, 2020, 10:00 ET PMB-Alcen Announces the Launch of FLASHKNiFE, the FLASH Radiotherapy System Dedicated to Clinical Trials

PMB, a subsidiary of the ALCEN group, is proud to announce the launch of FLASHKNiFE, the FLASH radiotherapy system dedicated to clinical trials....


Jun 24, 2020, 08:30 ET IMC Announces Efficacy of IMC Branded Strains in Reducing Migraines

Peer-reviewed study indicates two IMC branded medical cannabis strains were effective in reducing migraines in over 60% of treated patients Study...


Jun 23, 2020, 12:33 ET IgNova Files Patent Application on Antibody Against COVID-19

IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans....


Jun 23, 2020, 07:00 ET Oncolytics Biotech® Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the first patient has been dosed in the Company's phase 2 study of...


Jun 23, 2020, 03:00 ET Mental Health Care Company COMPASS Pathways Strengthens Leadership Team With Appointment of Trevor Mill as Chief Development Officer

COMPASS Pathways, a mental health care company, announced today that it has made a number of new appointments to its leadership team. Trevor Mill...


Jun 22, 2020, 11:00 ET ABM Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ABM-1310 in the USA

ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced that the first cancer...


Jun 18, 2020, 07:00 ET MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

MindMed will now pursue N,N-Dimethyltryptamine (DMT), the principally active ingredient in Ayahuasca, as part of its R&D collaboration with the...


Jun 17, 2020, 11:00 ET MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) Begins Patient Recruitment

Dr Carmen Escuriola-Ettingshausen and Dr Robert Sidonio are pleased to announce that MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with...


Jun 16, 2020, 09:30 ET Long-term, relapse-free survival data for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery presented at ASCO20

More than half of patients with BRAF-mutated advanced melanoma treated with Tafinlar + Mekinist were alive and free of a relapse at five years1 Study ...


Jun 16, 2020, 09:00 ET New Data Show Use of Abbott's FreeStyle® Libre System Reduces All-Cause, Diabetic Ketoacidosis-Related Hospitalization Rates and Acute Diabetes Events

Today, Abbott (NYSE: ABT) announced results from multiple new real-world studies1,2,3,4 that demonstrate how use of the FreeStyle Libre system, the...


Jun 16, 2020, 08:00 ET New Capture the Fracture® Partnership Aims for 25% Reduction in the Incidence of Hip and Vertebral Fractures Due to Osteoporosis by 2025

The International Osteoporosis Foundation (IOF) has today announced a partnership with Amgen and UCB, in collaboration with the University of Oxford, ...


Jun 15, 2020, 13:48 ET Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020

WINNIPEG, MB, June 15, 2020 /CNW/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is pleased to...


Jun 15, 2020, 08:16 ET Dompé Presents Phase II Clinical Trial Results for Ladarixin in New-Onset Type 1 Diabetes at the American Diabetes Association's Scientific Sessions

Dompé Farmaceutici S.p.A and Dompé U.S. Inc., (collectively Dompé) announced topline Phase 2 clinical trial (MEX0114) results for its investigational ...


Jun 13, 2020, 11:00 ET New Late-Breaking Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1C Levels in People with Type 2 Diabetes Using Insulin or Not

Today, Abbott (NYSE: ABT) announced new late-breaking data demonstrating use of its FreeStyle Libre system, the world's leading3 continuous glucose...